INVO Bioscience enters equity line with Triton Funds for up to $850k, issues warrants at $2.00

INVO Fertility, Inc.

Purchase Agreement to sell up to 1M shares at $0.85/share, gross proceeds up to $850k, expires Dec 31, 2024.
Private placement warrants to buy 1M shares at $2.00/share, exercisable for 5 years from issuance.
Stockholder approval may be required if issuances exceed 523,344 shares (19.9% of outstanding) under Nasdaq rules.
Warrants are unregistered; cashless exercise permitted if no effective registration statement.
Triton's beneficial ownership limited to 9.99% of outstanding common stock.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

INVO Fertility, Inc. entered into Purchase Agreement with Triton Funds LP valued at up to $850,000 (effective 2024-03-27).

Action: entry
Agreement: equity purchase
Counterparty: Triton Funds LP
Value: up to $850,000
Effective: 2024-03-27

Exact text from the filing

On March 27, 2024, INVO Bioscience, Inc., a Nevada corporation (the “ Company ”) entered into a purchase agreement (the “ Purchase Agreement ”) with Triton Funds LP (“ Triton ”), pursuant to which the Company agreed to sell, and Triton agreed to purchase, upon the Company’s request in one or more transactions, up to 1,000,000 shares of the Company’s common stock, par value $0.0001 per share, providing aggregate gross proceeds to the Company of up to $850,000.

View on SEC.gov

380 material agreements filed in the last 30 days. Browse all material agreements →

INVO Fertility, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-012858

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.